insights_auto
Bakit tumaas ang GMAB 3.65%?
Tingnan ang Higit pang Detalyechevron_right
GMAB:NASDAQ
Genmab
$36.02
arrow_upward
+3.65%(+1.27) 1D
Okt 5, 2:49:10 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa GMAB...
Buksan
$35.09
Mataas
$36.10
Mababa
$35.02
Mkt. cap
21.96B
Avg. na dami
2.55M
Dami
4.19M
P/E ratio
28.38
Mataas nang 52-wk
$36.10
Mababa nang 52-wk
$23.62
EPS
$1.27
Beta
0.81
Mga natitirang share
624.06M
Bilang ng mga empleyado
3K
Buksan
$35.09
Mataas
$36.10
Mababa
$35.02
Mkt. cap
21.96B
Avg. na dami
2.55M
Dami
4.19M
P/E ratio
28.38
Mataas nang 52-wk
$36.10
Mababa nang 52-wk
$23.62
EPS
$1.27
Beta
0.81
Mga natitirang share
624.06M
Bilang ng mga empleyado
3K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
AD HOC NEWS
·
2 oras ang nakalipas
Genmab stock after-hours at EUR 319.90: minus 0.03 percent versus the prior close at Lang & Schwarz
Investing.com UK
·
4 oras ang nakalipas
Genmab stock hits 52-week high at 35.95 USD By Investing.com
GuruFocus
·
4 oras ang nakalipas
GMAB Maintained by Guggenheim -- Price Target Raised to $54.00
Investing.com
·
7 oras ang nakalipas
Guggenheim raises Genmab stock price target on pipeline potential
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Tungkol sa Genmab
CEOJan G. J. van de Winkel
Mga Empleyado3.12K
ItinatagHun 11, 1998
Headquarters-
Sektor-
Websitegenmab.com